1.Sweet's Syndrome with Myelodysplastic Syndrome Progressing to Acute Myelogenous Leukemia.
Seung Ho CHANG ; Jai Il YOUN ; Yoo Shin LEE
Annals of Dermatology 1991;3(1):54-57
Sweet's syndrome is an important cutaneous sign of underlying myeloproliferative disorder. The majority of cases have occurred with acute leukemia, primarily of the myelogenous type. We described a case of Sweet's syndrome in a patient with myelodysplastic syndrome that preceded acute myelogenous leukemia by 9 months.
Humans
;
Leukemia
;
Leukemia, Myeloid, Acute*
;
Myelodysplastic Syndromes*
;
Myeloproliferative Disorders
;
Sweet Syndrome*
2.A Clinical Study of the Effects of Finasteride on Androgenetic Alopecia.
Seung Il KIM ; Jae Hak YOO ; Kea Jeung KIM
Annals of Dermatology 2000;12(4):264-270
BACKGROUND: The 5α-reductase inhibitor finasteride blocks the conversion of testosterone to dihydrotestosterone(DHT), the androgen responsible for androgen- etic alopecia in genetically predisposed men. OBJECTIVE: The purpose of this study was to determine the efficacy of finaster- ide treatment according to the type of androgenetic alopecia in Korea. METHODS: 196 patients with finasteride(1.25mg/day) were registered in this study and 68 patients were followed over 8 months. Efficacy was evaluated by globa1 photographs, investigator assessment of clinical change,and patients' self assessment via self administered hair growth questionnaire. RESULTS: Patients' self-assessment demonstrated that finasteride treatment slowed hair loss, increased hair growth, and improved appearance of hair. These improvements were corroborated by objective assessments after 4 months of treatment. Adverse effects such as sexual dysfunction were minimal. CONCLUSION: Oral finasteride 1.25mg/day slowed the progression of hair loss and increased hair growth in clinical tria1s of men with androgenetic alopecia over 8 months. With its generally good tolerability profile, finasteride is a new approach to the management of this condition, for which treatment options are few.
Alopecia*
;
Finasteride*
;
Hair
;
Humans
;
Korea
;
Male
;
Research Personnel
;
Self-Assessment
;
Testosterone
3.A case of generalized lipodystrophy.
Seung Ho CHANG ; Jai Il YOUN ; Yoo Shin LEE
Korean Journal of Dermatology 1991;29(2):241-246
Generalized lipodyst,rophy is characterized by generalized loss of body fat, and is asociated vith metabolic ahnormalities, including insulin resistance, hyperglycemia., and hypertriglyceridemia. like acanthosis nigricans, generalized lipodystrophy is a cutaneous marker of insulin re.istant diabetes. We report. herein a twenty year old female witti both classic generalized lipodystripin and acanthosis nigricans, in association with insulin resistant diabetes.
Acanthosis Nigricans
;
Adipose Tissue
;
Female
;
Humans
;
Hyperglycemia
;
Hypertriglyceridemia
;
Insulin
;
Insulin Resistance
;
Lipodystrophy, Congenital Generalized*
4.A case of Pierre-Robin syndrome.
Seung Ho HONG ; Seung Lyul YOO ; Kwang Il KIM ; Kap Sung OH
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(3):621-625
No abstract available.
Pierre Robin Syndrome*
5.Comparison of skin test and RAST in patients with allergic rhinitis.
Seung Lyul YOO ; Seung In HONG ; Sung Wan KIM ; Sung Mahn LEE ; Kwang Il KIM ; Sung Keun YOO
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(6):1212-1218
No abstract available.
Humans
;
Rhinitis*
;
Skin Tests*
;
Skin*
6.A Case of Tsutsugamushi Disease.
Chul Ho YOO ; Seung Hun LEE ; Jeon Han PARK ; Soo Il CHUN
Korean Journal of Dermatology 1989;27(2):206-210
Tsutsugamushi disease, an infectious disease by Rickettsia(R.) tsntsugamushi, is characterized by eschar, fever and rash. Eschar caused by chigger bite, is pre sent on 47 94% of patients with documented R. tsutsugamushi. We recently noticed one case of R. tsutsugamushi infection. Patient had fever, heaclache, lymphadenopathy, erythematous maculopapules and eschar. The R. tsu tsugamushi was isolated from serum of the patient. Histopathologic findings of eschar show epidermal ulceration overlying a zone of coagulative necrosis of upper dermis and necrotizing vasculitis. E]ectron microscopic findings of endothelial cells of capillary show rickettsia with cell division.
Capillaries
;
Cell Division
;
Communicable Diseases
;
Dermis
;
Endothelial Cells
;
Exanthema
;
Fever
;
Humans
;
Lymphatic Diseases
;
Necrosis
;
Rickettsia
;
Scrub Typhus*
;
Trombiculidae
;
Ulcer
;
Vasculitis
7.Neurologic complications in renal transplant recipients.
Seung Han SUK ; Kyoon HUH ; Yoo Sun KIM ; Ki Il PARK
The Journal of the Korean Society for Transplantation 1993;7(1):187-192
No abstract available.
Transplantation*
8.A case of neuroblastoma with multiple skin metastases.
Koo Il SEO ; Seung Yong JUNG ; Kyu Han KIM ; Jai IL YOUN ; Yoo Shin LEE ; Hyo Seop AHN
Korean Journal of Dermatology 1993;31(2):264-268
We report a case of neuroblastoma with multiple skin metastases as a chief complaint in a 2-month-old girl. the skin lesions were rnultiple, pea-sized, bluish, nontender, moable subcutaneous nodules on abdomen, back and scalp. Histopathology showed small round or poly gonal tumor cells which have deeply stained, basophilic, hyperchromatic nuclei with some mitoses. Th.se tumor cells showed clumping tendency which is one of early menifestations of rosette formation. Immunohistochemically positive reaction was demonstrated by anti-NSE(neuron specific enolase) antilody but negative reaction by anti-NFP (neurofilament proteiin ) antibody. She has been succesfully treated with combined chemotherapy for 10 months without relapse.
Abdomen
;
Basophils
;
Drug Therapy
;
Female
;
Humans
;
Infant
;
Mitosis
;
Neoplasm Metastasis*
;
Neuroblastoma*
;
Phosphopyruvate Hydratase
;
Recurrence
;
Rosette Formation
;
Scalp
;
Skin*
9.Radiologic Morphology of Proximal Femur: Comparison between Normal and Diseased Hips.
Hui Taek KIM ; Seung Wook KIM ; Jeung Il KIM ; Kuen Taek SUH ; Jeung Tak SUH ; Chong Il YOO
The Journal of the Korean Orthopaedic Association 1998;33(1):177-185
Diseases involving hip may influence on the anatomy of the proximal femur, especially on the endosteal canal shape. The simple radiographic comparative study was performed between normal and diseased hips. For the diseasd hip group, 74 hips ol' femoral head AVN(avascular necrosis) (average age: 49.3 years old, patients were all male) who had limped for average l9 months were selected and 77 male hips (average age: 48.9 years old) who had no prior hip disease were selected for the normal hip group. The external shape of both group showed no significant differences except for the femoral head dimensions. Statistically significant differences were ohserved hetween two groups in the proximal endosteal canal shape and cortical thickness. The femur of the diseased hip group had wider canal from the level of distal to lesser trochanter to the level of isthmus, with a significant reduction in the metaphyseal index (the ratio hetween the canal width proximal to lesser trochanter and distal to lesser trochanter) and the canal flare index (p<0.001). Theoretically this study suggests that the optimal fit and fill to the proximal endostcal canals of normal and diseased hips cannot be obtained by oneshape cementless femoral stcms.
Femur*
;
Head
;
Hip*
;
Humans
;
Male
10.Fixed Drug Eruption Caused by Piroxicam.
Sung Pil YOON ; Il Hwan LEE ; Seong Hun LEE ; Byung Su KIM ; Jae Hak YOO ; Seung Chul LEE
Korean Journal of Dermatology 1998;36(1):186-190
A fixed drug eruption is a cutaneous reaction caused by various drugs, which include phenazone derivatives, barbiturates, sulfonamides, tetracyclines and phenolphthaleins. An eruption caused by piroxicam is very rare and there have been no previous reports in Korea. A 49-year-old woman was seen with mutiple erythematous patches and some bullae that appeared after oral administration of piroxicam. The patient had had two similar episodes after oral administration of piroxicam. We performed patch test with piroxicam and could confirm a fixed drug eruption caused by this durg.
Administration, Oral
;
Antipyrine
;
Barbiturates
;
Drug Eruptions*
;
Female
;
Humans
;
Korea
;
Middle Aged
;
Patch Tests
;
Phenolphthalein
;
Phenolphthaleins
;
Piroxicam*
;
Sulfonamides
;
Tetracyclines